YUANPEI LI

YUANPEI LI

University of California, Davis

H-index: 35

North America-United States

About YUANPEI LI

YUANPEI LI, With an exceptional h-index of 35 and a recent h-index of 29 (since 2020), a distinguished researcher at University of California, Davis, specializes in the field of Drug Delivery, Nano-medicine, Molecular Imaging, Drug Development.

His recent articles reflect a diverse array of research interests and contributions to the field:

A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers

Deep tumor-penetrating nano-delivery strategy to improve diagnosis and therapy in patient-derived xenograft (PDX) oral cancer model and patient tissue

Hybrid telodendrimers

On-demand targeting nanotheranostics with stimuli-responsive releasing property to improve delivery efficiency to cancer

Porphyrin modified telodendrimers

SEMA3C supports pancreatic cancer progression by regulating the autophagy process and tumor immune microenvironment

Phototherapy with cancer-specific nanoporphyrin potentiates immunotherapy in bladder cancer

Transformable nanoparticles to bypass biological barriers in cancer treatment

YUANPEI LI Information

University

Position

Associate Professor

Citations(all)

6187

Citations(since 2020)

3412

Cited By

4069

hIndex(all)

35

hIndex(since 2020)

29

i10Index(all)

79

i10Index(since 2020)

68

Email

University Profile Page

University of California, Davis

Google Scholar

View Google Scholar Profile

YUANPEI LI Skills & Research Interests

Drug Delivery

Nano-medicine

Molecular Imaging

Drug Development

Top articles of YUANPEI LI

Title

Journal

Author(s)

Publication Date

A transformable nanoplatform with multiple therapeutic and immunostimulatory properties for treatment of advanced cancers

Biomaterials

Xiangdong Xue

Haijing Qu

Ruonan Bo

Dalin Zhang

Zheng Zhu

...

2023/8/1

Deep tumor-penetrating nano-delivery strategy to improve diagnosis and therapy in patient-derived xenograft (PDX) oral cancer model and patient tissue

Nano Research

Longmeng Li

Aaron R Lindstrom

Andrew C Birkeland

Menghuan Tang

Tzu-Yin Lin

...

2023/2

Hybrid telodendrimers

2022/6/28

On-demand targeting nanotheranostics with stimuli-responsive releasing property to improve delivery efficiency to cancer

Biomaterials

Hongwei Lu

Ji Xu

Jinfan Yang

Zhongling Wang

Peng Xu

...

2022/11/1

Porphyrin modified telodendrimers

2022/1/11

SEMA3C supports pancreatic cancer progression by regulating the autophagy process and tumor immune microenvironment

Frontiers in oncology

Dalin Zhang

Aaron Lindstrom

Edward J Kim

Chang-il Hwang

Madison Lee Hall

...

2022/6/16

Phototherapy with cancer-specific nanoporphyrin potentiates immunotherapy in bladder cancer

Clinical Cancer Research

Zheng Zhu

Ai-Hong Ma

Hongyong Zhang

Tzu-Yin Lin

Xiangdong Xue

...

2022/8/3

Transformable nanoparticles to bypass biological barriers in cancer treatment

Mythili Ramachandran

Zhao Ma

Kai Lin

Cristabelle De Souza

Yuanpei Li

2022

A mitochondria-targeting lipid–small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model

Acta Pharmaceutica Sinica B

Menghuan Tang

Kai Lin

Mythili Ramachandran

Longmeng Li

Hongye Zou

...

2022/6/1

Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effect

Biomaterials

Di Jing

Nian Jiang

Fengyi Wang

Chunping Mao

Shujun Han

...

2022/10/1

Light-triggered nitric oxide release and structure transformation of peptide for enhanced intratumoral retention and sensitized photodynamic therapy

Bioactive Materials

Lingdong Jiang

Danyang Chen

Zhaokui Jin

Chao Xia

Qingqing Xu

...

2022/6/1

A pH‐Driven Small‐Molecule Nanotransformer Hijacks Lysosomes and Overcomes Autophagy‐Induced Resistance in Cancer

Angewandte Chemie International Edition

Zhao Ma

Kai Lin

Menghuan Tang

Mythili Ramachandran

Reng Qiu

...

2022/8/26

Chidamide reverses fluzoparib resistance in triple-negative breast cancer cells

Frontiers in Oncology

Xinyang Li

Xiang Yuan

Ziming Wang

Jing Li

Zhiwei Liu

...

2022/2/18

Programmable bispecific nano-immunoengager that captures T cells and reprograms tumor microenvironment

Nano Letters

Lu Zhang

Ruonan Bo

Yi Wu

Longmeng Li

Zheng Zhu

...

2022/8/4

Stimuli‐responsive crosslinked nanomedicine for cancer treatment

Xiangdong Xue

Haijing Qu

Yuanpei Li

2022/12

The cationic amphiphilic drug hexamethylene amiloride eradicates bulk breast cancer cells and therapy-resistant subpopulations with similar efficiencies

Cancers

Anastasia L Berg

Ashley Rowson-Hodel

Michelle Hu

Michael Keeling

Hao Wu

...

2022/2/14

Engineered neuron-targeting, placental mesenchymal stromal cell-derived extracellular vesicles for in utero treatment of myelomeningocele

bioRxiv

Xinke Zhang

Hongyuan Chen

Kewa Gao

Siqi He

Zhao Ma

...

2021/9/24

LHRH‐Targeted Redox‐Responsive Crosslinked Micelles Impart Selective Drug Delivery and Effective Chemotherapy in Triple‐Negative Breast Cancer

Advanced healthcare materials

Kai Xiao

Qiangqiang Liu

Nell Suby

Wenwu Xiao

Rinki Agrawal

...

2021/2

Novel autophagy inhibitor to treat pancreatic cancer

Cancer Research

Mythili Ramachandran

Zhao Ma

Yuanpei Li

2021/7/1

Iron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy

Journal of controlled release

Xiangdong Xue

Marina Ricci

Haijing Qu

Aaron Lindstrom

Dalin Zhang

...

2021/1/10

See List of Professors in YUANPEI LI University(University of California, Davis)

Co-Authors

H-index: 95
Simon Cherry

Simon Cherry

University of California, Davis

H-index: 37
Douglas J Rowland

Douglas J Rowland

University of California, Davis

H-index: 35
Juntao Luo, Ph.D. Associate Professor

Juntao Luo, Ph.D. Associate Professor

SUNY Upstate Medical University

H-index: 30
Xiangdong Xue

Xiangdong Xue

Shanghai Jiao Tong University

H-index: 27
Hongyong Zhang (DVM, Ph.D.)

Hongyong Zhang (DVM, Ph.D.)

University of California, Davis

H-index: 26
Kai Xiao

Kai Xiao

Sichuan University

academic-engine